BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20920957)

  • 21. Retrospective multicentric study of pituitary incidentalomas.
    Day PF; Guitelman M; Artese R; Fiszledjer L; Chervin A; Vitale NM; Stalldecker G; De Miguel V; Cornaló D; Alfieri A; Susana M; Gil M
    Pituitary; 2004; 7(3):145-148. PubMed ID: 16328565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas.
    Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
    J Clin Endocrinol Metab; 2011 Apr; 96(4):964-71. PubMed ID: 21209028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical management of pituitary adenomas.
    Jane JA; Laws ER
    Singapore Med J; 2002 Jun; 43(6):318-23. PubMed ID: 12380732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary tumor registry: a novel clinical resource.
    Drange MR; Fram NR; Herman-Bonert V; Melmed S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):168-74. PubMed ID: 10634382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The diagnosis and therapy of subclinical pituitary adenoma apoplexy].
    Li JL; Yu CJ
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):879-81. PubMed ID: 16083609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients.
    Mortini P; Barzaghi R; Losa M; Boari N; Giovanelli M
    Neurosurgery; 2007 Jun; 60(6):993-1002; discussion 1003-4. PubMed ID: 17538372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
    Lu C; Lin XT; Yang DT; Liu YC; He WT; Zhong XL
    Chin Med J (Engl); 1989 Apr; 102(4):306-12. PubMed ID: 2551602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasopharyngeal presentation of pituitary tumors. Differential diagnosis and treatment.
    van der Lely AJ; Knegt PP; Stefanko SZ; Tanghe HL; Singh R; Lamberts SW
    J Clin Endocrinol Metab; 1992 Apr; 74(4):811-3. PubMed ID: 1548346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Epidemiology of Pituitary Adenomas.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):347-355. PubMed ID: 32741475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study.
    Agustsson TT; Baldvinsdottir T; Jonasson JG; Olafsdottir E; Steinthorsdottir V; Sigurdsson G; Thorsson AV; Carroll PV; Korbonits M; Benediktsson R
    Eur J Endocrinol; 2015 Nov; 173(5):655-64. PubMed ID: 26423473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina.
    Day PF; Loto MG; Glerean M; Picasso MF; Lovazzano S; Giunta DH
    Arch Endocrinol Metab; 2016; 60(6):554-561. PubMed ID: 27982201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of pituitary tumors: recent advances.
    Pickett CA
    Prim Care; 2003 Dec; 30(4):765-89. PubMed ID: 15024895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cushing's disease and prolactinoma].
    Führer D
    Dtsch Med Wochenschr; 2006 Jul; 131(30 Suppl 3):S82-6. PubMed ID: 16933198
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnosis and management of pituitary tumours.
    Levy A; Lightman SL
    BMJ; 1994 Apr; 308(6936):1087-91. PubMed ID: 8080517
    [No Abstract]   [Full Text] [Related]  

  • 36. The burden of disease for pituitary patients.
    Biermasz NR
    Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101309. PubMed ID: 31405752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies.
    Andela CD; Scharloo M; Pereira AM; Kaptein AA; Biermasz NR
    Pituitary; 2015 Oct; 18(5):752-76. PubMed ID: 25605584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term management and outcome for pituitary tumors.
    Ciric I
    Neurosurg Clin N Am; 2003 Jan; 14(1):167-71. PubMed ID: 12690987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of hypothalamic-pituitary tumors--experiences at Hiroshima University School of Medicine].
    Uozumi T
    Nihon Naibunpi Gakkai Zasshi; 1995 Nov; 71(7):1019-36. PubMed ID: 8582482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What Are Pituitary Adenomas?
    Voelker RA
    JAMA; 2023 Dec; 330(22):2224. PubMed ID: 37948091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.